552c7ae14ClaimRunning on OpenAI's GPT-5.5 model, MAI-DxO achieved about 85% accuracy on emergency department cases both with and without orchestration.AgreeDisagree
552c7ae14ClaimMicrosoft's MAI-DxO system achieved an 80.3% accuracy rate on emergency department admissions, compared to 46.8% for generalist physicians with internet access.AgreeDisagree
552c7ae14ClaimMicrosoft's MAI-DxO diagnostic system achieved an 83.2% accuracy rate on complex medical cases from the New England Journal of Medicine in a study published in Science on October 22, 2026.AgreeDisagree
552c7ae14ClaimIn the Science study, 304 complex cases published in the New England Journal of Medicine were evaluated without physical examinations or medical imaging available to the AI or human doctors.AgreeDisagree
552c7ae14ClaimMicrosoft compiled scenarios from medical case reports and emergency department data to create its SDBench benchmark.AgreeDisagree
552c7ae14ClaimResearchers measured how effectively MAI-DxO selected diagnostic tests rather than evaluating only final diagnostic accuracy.AgreeDisagree
552c7ae14ClaimDoctors should be allowed to prescribe undisclosed placebos when no effective treatment existsAgreeDisagree20
552c7ae14ClaimThe psychological effect on a patient of receiving a drug prescribed by a doctor is beneficial in itselfAgreeDisagree
552c7ae14ClaimPresident Donald Trump nominated wellness influencer Dr. Casey Means for surgeon general, but her nomination was withdrawn after Senate confirmation stalled over concerns regarding her medical experience and vaccine stancesAgreeDisagree
552c7ae14ClaimIn an October 22, 2026 statement announcing his resignation, Calley Means, a senior adviser to Health and Human Services Secretary Robert F. Kennedy Jr., expressed tremendous respect for President Donald Trump and Kennedy without stating a reasonAgreeDisagree
552c7ae14ClaimCalley Means and his statement on October 22, 2026 highlighted Make America Healthy Again policy achievements, including expanding access to psychedelics, overhauling dietary guidelines, and limiting SNAP benefits for sugary drinksAgreeDisagree
552c7ae14ClaimWhile serving at the Department of Health and Human Services, Calley Means attacked leading physician groups, federal agencies, and government scientists, claiming they protect their own interestsAgreeDisagree
552c7ae14ClaimThe United States Medicaid program faces nearly $1 trillion in federal funding cuts over the coming decadeAgreeDisagree
552c7ae14ClaimBarrister Peter Mant KC stated at the Lampard Inquiry that clinical effectiveness claims made by Oxevision manufacturer Lio Health were based on unverified anecdotes and unbacked by statistical evidence.AgreeDisagree
552c7ae14ClaimApproximately 25% of new prescription drugs launched in the U.S. in 2025 had annual net prices exceeding $500,000, while another 34% were priced between $200,000 and $500,000.AgreeDisagree
552c7ae14ClaimThe median net launch price of newly approved U.S. prescription drugs rose 35% after adjusting for inflation, increasing from $190,000 in 2022 to $257,000 in 2025, according to a report by ICER and West Health.AgreeDisagree
552c7ae14ClaimDonald Trump has formed more than a dozen deals asking drugmakers to adopt most-favored nation drug pricing in exchange for tariff relief.AgreeDisagree
552c7ae14ClaimThe median list price for newly approved U.S. prescription drugs, adjusted for inflation, rose 24% from 2022 to $293,000 in 2025.AgreeDisagree
552c7ae14ClaimTwo-thirds of newly approved prescription drugs reviewed by the Institute for Clinical and Economic Review between 2022 and 2025 were launched at prices exceeding ICER's cost-effectiveness thresholds.AgreeDisagree
552c7ae14ClaimFour in 10 prescription claims for the 26 new medicines reviewed by ICER between 2022 and 2025 were rejected by health insurers.AgreeDisagree